A
Aleš Linhart
Researcher at First Faculty of Medicine, Charles University in Prague
Publications - 371
Citations - 36568
Aleš Linhart is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Fabry disease & Medicine. The author has an hindex of 50, co-authored 333 publications receiving 30467 citations. Previous affiliations of Aleš Linhart include University Hospital of Wales & Charles University in Prague.
Papers
More filters
Journal ArticleDOI
CRT-127 Hyperinvasive Approach To Out-of Hospital Cardiac Arrest Using Mechanical Chest Compression Device, Prehospital Intraarrest Cooling, Extracorporeal Life Support And Early Invasive Assessment Compared To Standard Of Care. A Randomized Parallel Groups Comparative Study. “Prague Ohca Study". Results Of Presimulation And Simulation Phase
Jan Belohlavek,Ondrej Franek,Milana Pokorna,Jiri Danda,Vít Kandrnal,Martin Balik,Jan Horák,Ondrej Smid,Hana Skalická,Jaroslav Valasek,Vratislav Mrazek,Zdenek Schwarz,Aleš Linhart +12 more
TL;DR: In this paper, a prospective randomized study compared pre-hospital intra-arrest hypothermia with ECLS in out-of-hospital cardiac arrest (OHCA) patients.
Journal ArticleDOI
Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy.
David Zemanek,Josef Marek,Gabriela Dostálová,S. Magage,Lenka Roblová,Tomas Kovarnik,Aleš Linhart +6 more
TL;DR: In this article, the authors describe 6 male patients with genetically confirmed Fabry disease and symptomatic left ventricular outflow tract obstruction (LVOTO) who underwent transcatheter alcohol septal ablation with an immediate effect on the obstruction without any serious complications.
Journal ArticleDOI
Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale.
Milos Taborsky,Tomáš Skála,Renata Aiglova,Marián Fedorco,Josef Kautzner,Tomas Jandik,Vlastimil Vančura,Aleš Linhart,Martin Válek,Miloslav Novak,Petr Kala,Rostislav Polášek,Tomáš Roubíček,Alexandr Schee,Gerhard Hindricks,Nikolaos Dagres,Robert Hatalaj,Jiri Jarkovsky +17 more
TL;DR: In this paper, the authors evaluated the benefit of implantation of Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT-P in non-ischemic patients with reduced left ventricle ejection fraction (LVEF) and optimal pharmacotherapy without significant midwall myocardial fibrosis detected by cardiac magnetic resonance (CMR).
Journal Article
The role of uric acid and allopurinol therapy in cardiovascular disease
Aleš Linhart,Daniel Rob +1 more
TL;DR: The increasing evidence of experimental and clinical studies suggesting that uric acid may play a causal role in cardiovascular disorders pathogenesis and allopurinol therapy could provide a clinical benefit in the prevention and treatment in many of these conditions is summarized.
Journal ArticleDOI
Expertní konsenzus k praktickým aspektům spolupráce kardiologa a diabetologa v péči o pacienty s chronickým srdečním selháním s redukovanou ejekční frakcí
Martin Haluzik,Markéta Kubíčková,Jiří Veselý,Aleš Linhart,Martin Prázný,Jan Škrha,Miloš Táborský,Filip Málek +7 more
TL;DR: In this article, the authors show that glifloziny u diabetiků významných novinek v lecbě srdecniho selhani, ktere blokadou reabsorpce glukozy v proximalnim tubulu diky inhibici sodiko-glukozoveho kotransporteru 2 vedou ke sniženi glykemie navozenim glykosurie.